PAR 5.26% 27.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-45

  1. 4,086 Posts.
    lightbulb Created with Sketch. 6541
    It was a good read of the article you made reference to GG. to get a better understanding of the IND process, there is a fair bit involved but at the same time I believe we are in a good position...
    - PPS has been in the market (albeit different physical format) for 60 + years
    - We've already passed Phase II and many examples now (with aid of SAS program) with human cases.
    - We have staff that have experience with dealing with FDA
    - Our manufacturing process has been formulated (again, for X no of years), we have the batches ready to go.
    - Our CEO, and other senior management have a wealth of experience in this area and with submissions to the FDA themselves.
    - Primarily our drug works and is safe and is meeting a very large unmet need.

    The next phase will be interesting but I dare say we will need some amount of patience specially when us investors wont have much if any feedback on how its all going...Maybe I should shut my internet connection down for the next few months and not look at the SP? cool.png

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
27.0¢
Change
-0.015(5.26%)
Mkt cap ! $94.58M
Open High Low Value Volume
29.0¢ 29.5¢ 27.0¢ $127.6K 455.7K

Buyers (Bids)

No. Vol. Price($)
9 66463 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 6800 1
View Market Depth
Last trade - 16.10pm 26/04/2024 (20 minute delay) ?
Last
27.5¢
  Change
-0.015 ( 3.51 %)
Open High Low Volume
28.5¢ 29.0¢ 27.5¢ 116032
Last updated 15.55pm 26/04/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.